Similar articles

• [Effects of treatment with neuraminidase on the immunogenicity of ATPC tumor cells].

  Iorio AM, Rivosecchi P, Santoni A, Fabiani L. Iorio AM, et al. Boll Soc Ital Biol Sper. 1973 Mar 15;49(9):462-6. Boll Soc Ital Biol Sper. 1973. PMID: 4787510 Italian. No abstract available.
• Neuraminidase induced immunospecific destruction of transplantable experimental tumors.

  Sethi KK, Teschner M. Sethi KK, et al. Postepy Hig Med Dosw. 1974 Jan-Feb;28(1):103-20. Postepy Hig Med Dosw. 1974. PMID: 4816378 No abstract available.
• Neuraminidase-induced enhancement of tumor growth in mice.

  Froese G, Berczi I, Sehon AH. Froese G, et al. J Natl Cancer Inst. 1974 Jun;52(6):1905-8. doi: 10.1093/jnci/52.6.1905. J Natl Cancer Inst. 1974. PMID: 4834417 No abstract available.
• Tumor angiogenesis: therapeutic implications.

  Folkman J. Folkman J. N Engl J Med. 1971 Nov 18;285(21):1182-6. doi: 10.1056/NEJM197111182852108. N Engl J Med. 1971. PMID: 4938153 Review. No abstract available.
• BCG and cancer (first of two parts).

  Bast RC Jr, Zbar B, Borsos T, Rapp HJ. Bast RC Jr, et al. N Engl J Med. 1974 Jun 20;290(25):1413-20. doi: 10.1056/NEJM197406202902506. N Engl J Med. 1974. PMID: 4364286 Review. No abstract available.